African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2284

Full Length Research Paper

Changes in nitric oxide levels and erythrocyte arginase activities in patient with Down syndrome

Ulku Ozbey1*, Ayse Seyran2, Mine Erisir3, Fulya Benzer4 and Yuksel Savucu5
1Department of Genetics, Faculty of Veterinary, Yuzuncu Yil University, 65080, Van, Turkey. 2Department of Biochemistry, Faculty of Health of Science, Bitlis Eren University, Bitlis, Turkey. 3Department of Biochemistry, Faculty of Veterinary, Firat University, 23119, Elazig, Turkey. 4Tunceli University, Health Highschool, 62000, Tunceli, Turkey. 5Department of Physical Education and Sports School, Firat University, 23119 Elazig, Turkey.
Email: [email protected]

  •  Accepted: 01 January 2012
  •  Published: 22 January 2012

Abstract

Down syndrome is a chromosome abnormality with specific clinical symptoms and mental retardation caused by trisomy of chromosome 21. There is evidence that oxygen free radicals play an important role in the pathophysiology of many neuropsychiatric disorders. Although, it has not been investigated yet, several recent studies proposed that nitric oxide related to oxidative stress and arginase may have a pathophysiological role in mental retardation. The purpose of this study was to determine plasma nitric oxide levels and erythrocyte arginase activities in patients with Down syndrome and in healthy children. Plasma nitric oxide levels and erythrocyte arginase activity were measured in 20 patients with Down syndrome (median age: 15.6 ± 7.5) and 20 age-matched healthy subjects (median age: 16.2 ± 7.4). Significant differences were found between erythrocyte arginase activity of the patients with Down syndrome (35.2 ± 2.7 U/g hemoglobin (Hb)) and those of healthy children (43.5 ± 2.9 U/g Hb), (P < 0.05). But we have not found any statistical difference between persons with Down syndrome and control group for nitric oxide (P > 0.05). It was concluded that the level of erythrocyte arginase activity could be considered as a useful marker for assessing the level of mental retardation in children with Down syndrome.

 

Key words: Down syndrome, erythrocyte arginase, nitric oxide, mental retardation, oxidative stress.